Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer

NAPOLI-1 (NCT01494506) was a phase III study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy. This post hoc analysis of NAPOLI-1 aimed to develop a predic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Li-Tzong Chen, Teresa Macarulla, Jean-Frédéric Blanc, Beloo Mirakhur, Floris A. de Jong, Bruce Belanger, Tanios Bekaii-Saab, Jens T. Siveke
Format: Artigo
Langue:Inglês
Publié: MDPI AG 2019-07-01
Collection:Cancers
Sujets:
liposomal irinotecan
NAPOLI-1
nomogram
pancreatic cancer
survival outcomes
Accès en ligne:https://www.mdpi.com/2072-6694/11/8/1068
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires